Direct-To-Consumer Genetics and Health Policy: A Worst-Case Scenario?

American Journal of Bioethics 9 (6-7):48-50 (2009)
  Copy   BIBTEX

Abstract

There is currently little evidence that the information provided by personal genomics companies—such as 23andMe and Navigenics—on a direct-to-consumer (DTC) basis, has any real health value. To be...

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 101,174

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Direct-to-consumer genomics and personal health data.Jorge L. Contreras - 2021 - In I. Glenn Cohen, Nita A. Farahany, Henry T. Greely & Carmel Shachar (eds.), Consumer genetic technologies: ethical and legal considerations. New York, NY: Cambridge University Press.
Re-examining the Gene in Personalized Genomics.Jordan Bartol - 2013 - Science & Education 22 (10):2529-2546.

Analytics

Added to PP
2010-09-14

Downloads
26 (#855,855)

6 months
6 (#869,904)

Historical graph of downloads
How can I increase my downloads?